With 0.82 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.34 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $17.3 whereas the lowest price it dropped to was $15.09. The 52-week range on OPRX shows that it touched its highest point at $18.22 and its lowest point at $3.78 during that stretch. It currently has a 1-year price target of $19.00. Beta for the stock currently stands at 1.17.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of OPRX was up-trending over the past week, with a rise of 25.82%, but this was up by 27.40% over a month. Three-month performance surged to 61.96% while six-month performance rose 193.12%. The stock gained 232.92% in the past year, while it has gained 95.41% so far this year. A look at the trailing 12-month EPS for OPRX yields -0.54 with Next year EPS estimates of 0.77. For the next quarter, that number is 0.04. This implies an EPS growth rate of 97.40% for this year and 17.54% for next year.
Float and Shares Shorts:
At present, 18.56 million OPRX shares are outstanding with a float of 16.75 million shares on hand for trading. On 2025-07-15, short shares totaled 1.15 million, which was 620.0 higher than short shares on 1749772800. In addition to Mr. Stephen L. Silvestro as the firm’s President & CEO, Mr. Edward Stelmakh C.M.A., M.B.A. serves as its CFO & COO.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, OPRX reported revenue of $29195000.0 and operating income of $3189000.0. The EBITDA in the recently reported quarter was $4390000.0 and diluted EPS was $0.08.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for OPRX since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With OPRX analysts setting a high price target of 27.0 and a low target of 11.0, the average target price over the next 12 months is 18.0. Based on these targets, OPRX could surge 66.87% to reach the target high and fall by -32.01% to reach the target low. Reaching the average price target will result in a growth of 11.25% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.37263 being high and $0.27681 being low. For OPRX, this leads to a yearly average estimate of $0.30875. The surprise factor in the prior quarter was -$0.12. Based on analyst estimates, the high estimate for the next quarter is $0.49 and the low estimate is $0.15. The average estimate for the next quarter is thus $0.34.
